Annual report pursuant to Section 13 and 15(d)

Schedule of Earnings Per Share, Basic and Diluted (Details)

v3.10.0.1
Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Net loss attributable to Orgenesis Inc $ 18,291 $ 12,367
Adjustment of redeemable non-controlling interest to redemption amount 884 0
Net loss attributable to Orgenesis Inc. for loss per share $ 19,175 $ 12,367
Weighted average number of common shares outstanding 13,374,103 9,679,964
Basic loss per common share $ 1.43 $ 1.28
Net loss attributable to Orgenesis Inc. for loss per share $ 19,175 $ 12,367
Changes in fair value of embedded derivative and interest expense on convertible loans 0 392
Loss for the year $ 19,175 $ 12,759
Number of dilutive shares related to convertible note 0 34,288
Weighted average number of common shares outstanding 13,374,103 9,714,252
Diluted loss per common share $ 1.43 $ 1.31